Oral Anticoagulation in 2024: Lessons from Randomized Trials
Explore the latest insights on oral anticoagulation from randomized trials, presented by expert John Eikelboom in this comprehensive grand rounds session.
Between Crime and Innocence: Is Patent Foramen Ovale Guilty?
Explore the controversial role of patent foramen ovale in cardiovascular health with Dr. Mohammed Abalhassan's in-depth analysis of its potential guilt or innocence.
Intravenous Antiplatelet Agents
Dive into the world of intravenous antiplatelet agents with Dr. Maen Assali, exploring their applications and impacts in cardiovascular medicine.
Restarting Anticoagulation After Bleeding - Whether, When and How
Gain insights into evidence-based strategies for managing anticoagulation after bleeding events, including timing considerations and optimal approaches for patient care and safety.
Defining the Role of Dual Antiplatelet Therapy After Coronary Artery Bypass Surgery
Explore evidence-based insights into dual antiplatelet therapy's role following coronary bypass surgery, focusing on optimal treatment strategies and patient outcomes.
The Next Horizon of Anticoagulation - Current and Future Research Priorities
Explore cutting-edge developments in anticoagulation therapy, from current research findings to emerging treatment strategies and future clinical applications in cardiovascular medicine.
Factor V Leiden - Hypercoagulability
Explore Factor V Leiden, a genetic disorder causing hypercoagulability. Learn about its pathophysiology, clinical implications, and relationship to venous thromboembolism risk.
Protein C and Protein S
Explore the roles of Protein C and S in blood coagulation, their vitamin K dependency, and related disorders like Factor V Leiden and warfarin-induced skin necrosis.
Peripheral Artery Disease
Comprehensive overview of peripheral artery disease, covering pathophysiology, causes, symptoms, complications, diagnosis, and treatment, with practice cases for applied learning.
Coagulation in COVID-19 Infection - Understanding the Implications
Expert-led seminar exploring coagulation issues in COVID-19 infections, discussing implications and impact on pathology. Insights from Professor Beverley Hunt on thrombosis and hemostasis in the pandemic context.
Liver Disease and Hemostasis Disorders
Explore liver disease's impact on hemostasis, including bleeding and thrombosis risks. Learn about vitamin K deficiency, factor XIII and X deficiencies, and their effects on coagulation.
Paroxysmal Nocturnal Hemoglobinuria - Etiopathogenesis and Clinical Features
Explore etiopathogenesis and clinical features of Paroxysmal Nocturnal Hemoglobinuria (PNH) based on Harrison's principles, presented by Dr. Debapriyo.
Treatment of Thrombotic Antiphospholipid Syndrome (APS)
Explore treatment strategies for thrombotic Antiphospholipid Syndrome with expert insights on management approaches and latest recommendations.
2023 ACR/EULAR AntiPhospholipid Syndrome Classification Criteria
Explore the new 2023 ACR/EULAR classification criteria for AntiPhospholipid Syndrome (APS), providing a critical overview for healthcare professionals in vascular medicine and rheumatology.
Future Strategies for Anticoagulation in Cardiovascular Disease - 13 March 2024
Explore future anticoagulation strategies in cardiovascular disease with Stanford experts, covering latest advancements and clinical implications.
Factor Clotting Disorders - Medical Review
Explore factor clotting disorders, their mechanisms, and clinical implications in this concise medical review for licensing exam preparation.
How to Explain the Antiphospholipid Profile to Patients
Understand antiphospholipid antibody test results using simple language. Learn to interpret and communicate aPL profiles effectively for patients with AntiPhospholipid Syndrome (APS).
Anticoagulation in Elderly Frail Patients
Explore anticoagulation strategies for elderly frail patients with expert insights from Prof. Dentali and Prof. Tuttolomondo in this comprehensive EFIM webinar.
Anticoagulation Following Ischemic Stroke and Intracranial Hemorrhage
Gain insights into evidence-based approaches for managing anticoagulation after stroke and hemorrhage, including timing, medication selection, and risk assessment strategies.
To Bleed or Not to Bleed - Anticoagulation in Patients with Non-valvular Atrial Fibrillation and End Stage Renal Disease
Explore the complex decision-making process of anticoagulation therapy in atrial fibrillation patients with end-stage renal disease, focusing on patient selection and emerging treatment approaches.